Atripla Sales Data

Rank 15 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Atripla U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 15 (1) 0.36% -0.23%
Q3 2013 14 (1) -5.24% -7.74%
Q2 2013 13 -1.24% -2.92%
Q1 2013 13 4.03% -0.83%
Q4 2012 13 (1) 0.46% 1.68%
Q3 2012 12 (4) 1.34% -0.42%
Q2 2012 16 (1) -1.70% -2.45%
Q1 2012 17 (2) 5.61% 1.45%
Q4 2011 19 (1) 4.92% 4.78%
Q3 2011 20 (2) 0.42% 0.88%
Q2 2011 22 6.31% 1.79%
Q1 2011 22

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
April 22, 2013FDA recently approved changes to the Atripla
Hide
(web2)